Unigene Claims $64.2M Liabilities In Ch. 7 Petition

Law360, New York (July 03, 2013, 4:58 PM ET) -- New Jersey-based Unigene Laboratories filed for Chapter 7 bankruptcy on Tuesday, declaring $64.2 million in liabilities after defaulting on repayments to a private equity firm and the company's founders.

The filing follows a troubling year for the drugmaker, including a loss of revenue from its osteoporosis nasal spray, Fortical, with warnings earlier this year that if the company failed to restructure debt owed to Victory Park Capital and its founders, it wouldn't be able to continue operations, according to regulatory filings.

The company lists $394,022 in...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers